{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Episode 477: A Boatload of Data on Omega-3 Benefits","description":"This week, Dr. Kahn dives into four new research papers on omega-3 fatty acids and their impact on heart and brain health. The discussion highlights several eye-opening findings, including reduced atrial fibrillation risk and improved cardiovascular outcomes in patients undergoing hemodialysis. Dr. Kahn also explains how omega-3 intake supports brain health and why the \u201cright\u201d dose depends on the specific condition being addressed. Food sources, fish oil, algae-based supplements, and ahiflower are compared as practical ways to reach optimal omega-3 levels.&amp;nbsp; Additional topics in this episode include newly approved AI software for early detection of heart disease, the role of statins in patients with type 2 diabetes, the science\u2014and hype\u2014around NAD+ boosters, and emerging data on Prolon fasting for Crohn\u2019s disease. Dr. Kahn also reviews concerning research on heart rhythm risks associated with high-intensity endurance exercise in athletes over the age of 50. As always, the episode blends cutting-edge research with real-world clinical insight to help clarify what actually matters for long-term heart health. Thanks to The Fresh Pressed Olive Oil Club \u2014 get a bottle for $1 at getfreshDRKAHN.com.&amp;nbsp; More About This Episode This episode takes a deeper look at why omega-3 blood levels matter more than simply taking a supplement. Dr. Kahn reviews large population studies linking higher omega-3 levels to lower risks of atrial fibrillation, early-onset dementia, and major cardiovascular events, including in high-risk groups such as patients on hemodialysis. The key takeaway: testing omega-3 status and personalizing intake may be far more effective than a one-size-fits-all approach.&amp;nbsp; Beyond omega-3s, Dr. Kahn explores several timely and surprising topics, including AI-enhanced CT scan technology designed to detect silent heart disease without additional radiation, real-world data on statin benefits in patients with type 2 diabetes, and why costly NAD+ supplements may ultimately function as a form of vitamin B3. The episode also examines new evidence on fasting-mimicking diets for Crohn\u2019s disease and potential heart rhythm risks in high-level endurance athletes over 50. Throughout the discussion, Dr. Kahn emphasizes practical, evidence-based steps patients can review with their physicians, including omega-3 blood testing, coronary calcium scoring, and tailoring lifestyle and supplement strategies to individual risk factors. ","author_name":"Heart Doc VIP with Dr. Joel Kahn","author_url":"https:\/\/www.kahnlongevitycenter.com\/","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/39795255\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/item\/39795255"}